These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 3125827)

  • 1. [The HIV problem of factor VIII-substituted hemophiliacs from the diagnostic and prognostic viewpoints].
    Wernet P; Göhring S; Sugg U; Brackmann HH; Kessler M; Egli H; Schneider W
    Beitr Infusionther Klin Ernahr; 1987; 18():21-4. PubMed ID: 3125827
    [No Abstract]   [Full Text] [Related]  

  • 2. LAV/HTLV-III seroconversion and disease in hemophiliacs treated in France.
    Mathez D; Leibovitch J; Sultan Y; Maisonneuve P
    N Engl J Med; 1986 Jan; 314(2):118-9. PubMed ID: 3079879
    [No Abstract]   [Full Text] [Related]  

  • 3. Detection of antibody to LAV/HTLV-III in sera from hemophiliacs in China.
    Zeng Y; Fan J; Zhang Q; Wang PC; Tang DJ; Zhon SC; Zheng XW; Liu DP
    AIDS Res; 1986 Dec; 2 Suppl 1():S147-9. PubMed ID: 3103638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of antibodies to LAV/HTLV III in hemophiliacs with the use of virus-inactivated clotting factors.
    Dietz B; Klose HJ; Gürtler L; Eberle J; Deinhardt F; Köhler-Vajta K; Peller P
    Thromb Haemost; 1986 Aug; 56(1):50-2. PubMed ID: 3095947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HTLV III antibodies and immunological alterations in hemophilia patients.
    Seifried E; Pindur G; Stötter H; Porzsolt F; Rasche H; Erfle V; Hehlmann R; Heimpel H
    Klin Wochenschr; 1986 Feb; 64(3):115-24. PubMed ID: 3005759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemophilia and HTLV-III infection].
    Lechler E
    Z Hautkr; 1986 Dec; 61(23):1687-704. PubMed ID: 2949442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of antibodies to AIDS-associated retrovirus in in- and out-patients in Japan.
    Ikegami N
    AIDS Res; 1986 Dec; 2 Suppl 1():S29-34. PubMed ID: 3103640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical, immunological, and virological aspects in Japanese hemophiliacs and AIDS patients.
    Abe T
    AIDS Res; 1986 Dec; 2 Suppl 1():S141-6. PubMed ID: 3103637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [HTLV-III antibodies and immunologic changes in hemophilic children. Prevalence of HTLV-III antibodies in hemophilic children and their relatives living in the same household].
    Zenz W; Muntean W; Teubl I; Beaufort F; Heinz FX
    Padiatr Padol; 1987; 22(1):33-41. PubMed ID: 3108827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of hemophiliacs with inhibitors].
    Fujimaki M
    Rinsho Ketsueki; 1985 Jul; 26(7):1059-68. PubMed ID: 3932719
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunological status and HIV antibodies in patients with haemophilia--a longitudinal study.
    Fuchs D; Hausen A; Reibnegger G; Werner ER; Vinazzer H; Dierich MP; Wachter H
    Wien Klin Wochenschr; 1988 Aug; 100(15):505-9. PubMed ID: 3140497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and transmission of human immunodeficiency virus in Japan.
    Kurimura T; Kawatani T; Hattori N; Tsuchie H
    AIDS Res; 1986 Dec; 2 Suppl 1():S163-6. PubMed ID: 3103639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of HIV antibodies in hemophiliacs in Buenos Aires.
    Muchinik GR; Anselmo AA; Picchio GR; Livellara B; Martín E; Bouzas MB; Pérez Bianco R; de Tezanos Pinto M
    Medicina (B Aires); 1987; 47(4):367-70. PubMed ID: 3452726
    [No Abstract]   [Full Text] [Related]  

  • 14. [Sequential examination of anti-human immunodeficiency virus (HIV) antibodies by Western blot analysis and immunity in hemophiliacs].
    Toyoda Y; Tonouchi T; Mimaya J; Takahashi S; Sugiyama T
    Rinsho Ketsueki; 1988 Apr; 29(4):513-9. PubMed ID: 3043040
    [No Abstract]   [Full Text] [Related]  

  • 15. AIDS: a problem for the transfusion service?
    Barbara JA; Contreras M; Hewitt P
    Br J Hosp Med; 1986 Sep; 36(3):178-84. PubMed ID: 3094615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acquired immune deficiency syndrome in hemophiliac subjects].
    Ogata K; Sugihara T; Kamiya T; Saito H
    Rinsho Byori; 1987 Feb; 35(2):141-6. PubMed ID: 3647140
    [No Abstract]   [Full Text] [Related]  

  • 17. T-cell alterations in hemophiliacs treated with commercial clotting factor concentrates.
    Lechner K; Niessner H; Bettelheim P; Deutsch E; Fasching I; Fuhrmann M; Hinterberger W; Korninger C; Neumann E; Liszka K
    Thromb Haemost; 1983 Aug; 50(2):552-6. PubMed ID: 6314582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and biological survey of haemophilia A and B patients infused with French heat-treated concentrates.
    Parquet A; Boneu B; Bosser C; Cazenave JP; Dirat G; Gazengel G; Grunebaum L; Sultan Y; Verroust F; Wiesel ML
    Nouv Rev Fr Hematol (1978); 1988; 30(4):205-7. PubMed ID: 3143099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to HIV in Israeli hemophiliacs: relationship between serological profile and disease development.
    Orgad S; Malone G; Zaizov R; Marinowitz U; McLane MF; Umiel T; Cohen IJ; Vogel R; Cohen-Avishai O; Ramot B
    AIDS Res Hum Retroviruses; 1987; 3(3):323-32. PubMed ID: 3124874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transmission of the human immunodeficiency virus by a dry heat-treated Factor VIII concentrate?].
    Weisser J
    Klin Padiatr; 1988; 200(5):375-9. PubMed ID: 3141670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.